208 related articles for article (PubMed ID: 17525480)
1. Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas.
Tischler AS
Endocr Pathol; 2006; 17(4):321-8. PubMed ID: 17525480
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
[TBL] [Abstract][Full Text] [Related]
3. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
Perren A; Komminoth P
Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482
[TBL] [Abstract][Full Text] [Related]
4. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract][Full Text] [Related]
5. Update on Paragangliomas and Pheochromocytomas.
Lam AK
Turk Patoloji Derg; 2015; 31 Suppl 1():105-12. PubMed ID: 26177321
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma and extra-adrenal paraganglioma: updates.
Tischler AS
Arch Pathol Lab Med; 2008 Aug; 132(8):1272-84. PubMed ID: 18684026
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
[TBL] [Abstract][Full Text] [Related]
8. Familial pheochromocytomas and paragangliomas.
King KS; Pacak K
Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers of paragangliomas/pheochromocytomas.
Zhikrivetskaya SO; Snezhkina AV; Zaretsky AR; Alekseev BY; Pokrovsky AV; Golovyuk AL; Melnikova NV; Stepanov OA; Kalinin DV; Moskalev AA; Krasnov GS; Dmitriev AA; Kudryavtseva AV
Oncotarget; 2017 Apr; 8(15):25756-25782. PubMed ID: 28187001
[TBL] [Abstract][Full Text] [Related]
10. Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.
Mete O; Tischler AS; de Krijger R; McNicol AM; Eisenhofer G; Pacak K; Ezzat S; Asa SL
Arch Pathol Lab Med; 2014 Feb; 138(2):182-8. PubMed ID: 24476517
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
15. An update on the genetics of pheochromocytoma.
Karasek D; Shah U; Frysak Z; Stratakis C; Pacak K
J Hum Hypertens; 2013 Mar; 27(3):141-7. PubMed ID: 22648268
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
Elder EE; Elder G; Larsson C
J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371
[TBL] [Abstract][Full Text] [Related]
17. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z
Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839
[TBL] [Abstract][Full Text] [Related]
18. The genetic basis of pheochromocytoma.
Gimm O; Koch CA; Januszewicz A; Opocher G; Neumann HP
Front Horm Res; 2004; 31():45-60. PubMed ID: 14674304
[TBL] [Abstract][Full Text] [Related]
19. A Guide to Pheochromocytomas and Paragangliomas.
Guilmette J; Sadow PM
Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301
[TBL] [Abstract][Full Text] [Related]
20. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.
Favier J; Igaz P; Burnichon N; Amar L; Libé R; Badoual C; Tissier F; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
Endocr Pathol; 2012 Mar; 23(1):34-42. PubMed ID: 22183643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]